About Zenara

Zenara provides high quality drug product formulations as a specialty contract development and contract manufacturing organisation for the pharmaceutical industry.

Key products and services:

  • Drug product formulation development of solid oral dosage forms
  • Drug product formulation manufacturing of solid oral dosage forms
  • Drug product technology transfers of solid oral dosage forms
  • Nicotine Replacement Therapy (NRT) products and development including medicated chewing gums and lozenges

Ownership

Zenara is a wholly owned subsidiary of Cambrex, an innovative life sciences company providing products, services and technologies to accelerate the development and commercialization of small molecule therapeutics.

With a network of R&D and cGMP manufacturing facilities located in the US, Europe and India, Cambrex offers a variety of technology-driven products and services for generic and branded pharmaceuticals:

  • Generic APIs
  • Advanced intermediates
  • Contract development and manufacturing

Cambrex is headquartered in East Rutherford, NJ, USA and is listed on the NYSE (CBM).